Meta and Google's content rules are restrictive for many abortion-rights groups worldwide, while abortion ads on Google aren't permitted in dozens of countries
Issie Lapowsky / Protocol : Tweets: @issielapowsky , @rti_digital , @evan_greer , @issielapowsky , @issielapowsky , and @issielapowsky Tweets: Issie Lapowsky / @issielapowsky : Meanwhile on Facebook, Women on Web has had its pages repeatedly taken down, ads rejected and posts that seem to follow every letter of the rules taken down. Like the post down left that reads: “Abortion should be a private matter.” https://www.protocol.com/... https://twitter.com/... @rti_digital : Our CEO @StephanieWDC spoke with Protocol about the troubling trend of ad platforms making it more difficult to message on abortion at this critical moment. https://www.protocol.com/... Evan Greer / @evan_greer : “This is why we need to be just as concerned about the power that platforms have to suppress speech as we are about the power they have to amplify it” Spoke to @issielapowsky for this story about companies like Meta and Google suppressing abortion content https://www.protocol.com/... Issie Lapowsky / @issielapowsky : NEW: How will Meta and Google respond to online speech about abortion in a post-Roe America? Look abroad, where abortion rights groups like Women on Web have already been playing a content moderation cat and mouse game with major US companies for years. https://www.protocol.com/... Issie Lapowsky / @issielapowsky : It's esp. tricky for groups posting/advertising about abortion pills. In almost every country, Google prohibits the words mifepristone and misoprostol from appearing in either the text of an ad OR the landing page the ad directs to. https://www.protocol.com/... Issie Lapowsky / @issielapowsky : Something I hadn't realized before reporting this story for eg.: Google prohibits abortion ads from running at all in dozens of countries. Huge impediment to info sharing abroad (and Google wouldn't/couldn't point me to any laws that actually prohibit ads) https://www.protocol.com/... https://twitter.com/...
Context & Ripple Effects
Google's restrictions on abortion advertising are not new: it banned all ads around the Irish abortion referendum in 2018, then after backlash required US, UK, and Irish advertisers to disclose whether they actually provide abortions under its abortion-services ad disclosure rules. What the Protocol reporting adds is the global scope — ads are barred outright in dozens of countries, and words like mifepristone and misoprostol cannot appear in ad text at all.
Meta's parallel record is enforcement-driven rather than policy-driven: Women on Web has had pages repeatedly removed, ads rejected, and posts taken down even when they appear to comply with stated rules. Together the two platforms sit between abortion-rights groups and the audiences they need to reach.
First-order effects
- Women on Web and similar groups lose their primary distribution channels — Meta's takedowns and Google's keyword and country bans directly cut off paid and organic reach for information about medication abortion.
- In countries where Google prohibits abortion ads entirely, providers cannot buy visibility at all, leaving search results shaped by whoever can appear organically.
Second-order effects
- The enforcement gap favors anti-abortion actors: Google Maps in the US has been found steering searches for abortion providers toward non-medical crisis pregnancy centers, so restrictive ad rules plus misdirected discovery compound each other.
- Groups pushed off mainstream ad infrastructure migrate to online pharmacies and direct-to-patient channels — a space where ProPublica later found most sellers sharing visitor data through third-party trackers like Google Analytics, creating new privacy exposure.
Third-order effects
- Platform content policies are functioning as de facto health-information gatekeepers across borders, with private moderation decisions — not national law alone — determining who can find reproductive-health services.
- If the pattern holds, expect mounting regulatory scrutiny of how platforms handle sensitive-health categories end to end, from ad eligibility to location-data promises like the clinic-visit deletion pledge Google made but was later found not consistently honoring.
The trend: Reproductive-health information is increasingly mediated by a small set of ad and social platforms whose opaque, inconsistently enforced policies decide which groups reach patients worldwide.